Work

Abstract 4230: Preclinical characterization of ATG-042, a novel MTAP null-selective PRMT5 inhibitor

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4230

Authors: Ya Kong, Ge Lin, Ming Zhang, Peng Chen, Jay Mei, Bing Hou

Institution: Antengene Corporation Limited (China)

Language: English

Topic: Cancer-related gene regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409634747

Cites:

Cited by:

Related to: 10